Position in GRFS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$141,496
-$11,104 QoQ
Shares Held
17,643
+8.1% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Ascent Group, LLC holds $68,984,188 across 14 Drug Manufacturers - General names. GRFS ranks #14 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
68,802 | $16,817,958 | |
| 2 | LLY |
ELI LILLY & Co
|
17,302 | $15,913,856 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
62,184 | $8,666,581 | |
| 4 | ABBV |
AbbVie Inc.
|
33,359 | $7,255,246 | |
| 5 | PFE |
Pfizer Inc
|
184,580 | $5,183,005 | |
| 6 | MRK |
Merck & Co., Inc.
|
37,190 | $4,473,583 | |
| 7 | AMGN |
Amgen Inc
|
7,925 | $2,788,410 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
38,067 | $2,308,762 |
All Filings in GRFS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $141,496 | 17,643 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $152,600 | 16,321 | Shares | Other | 2026-01-20 | |
| 2025-09-30 | $175,265 | 17,597 | Shares | Other | 2025-10-20 | |
| 2025-06-30 | $141,439 | 15,646 | Shares | Other | 2025-07-21 | |
| No filing history on record for this holder in this stock. | ||||||